We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns ...

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to ...

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

Shares in 5,432 companies trade every day starting at 9:30 on the New York Stock Exchange or Nasdaq ... week’s respective drops of 17% and 18%. Pfizer fell another 1% Monday, for a total ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

Pfizer (NYSE:PFE) recently made headlines with a strategic collaboration with Guardant Health, aimed at enhancing its ...

NEW YORK, April 10, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of ...